Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation

Objective. To investigate intrathecal immune activation parameters and HIV-RNA in HIV-associated neurocognitive disorders (HAND) of advanced naïve HIV-infected patients and to evaluate their dynamics before and after initiation of antiretroviral therapy (ART). Methods. Cross-sectional and longitudin...

Full description

Saved in:
Bibliographic Details
Main Authors: Monica Airoldi, Alessandra Bandera, Daria Trabattoni, Benedetta Tagliabue, Beatrice Arosio, Alessandro Soria, Veronica Rainone, Giuseppe Lapadula, Giorgio Annoni, Mario Clerici, Andrea Gori
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2012/467154
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564565607448576
author Monica Airoldi
Alessandra Bandera
Daria Trabattoni
Benedetta Tagliabue
Beatrice Arosio
Alessandro Soria
Veronica Rainone
Giuseppe Lapadula
Giorgio Annoni
Mario Clerici
Andrea Gori
author_facet Monica Airoldi
Alessandra Bandera
Daria Trabattoni
Benedetta Tagliabue
Beatrice Arosio
Alessandro Soria
Veronica Rainone
Giuseppe Lapadula
Giorgio Annoni
Mario Clerici
Andrea Gori
author_sort Monica Airoldi
collection DOAJ
description Objective. To investigate intrathecal immune activation parameters and HIV-RNA in HIV-associated neurocognitive disorders (HAND) of advanced naïve HIV-infected patients and to evaluate their dynamics before and after initiation of antiretroviral therapy (ART). Methods. Cross-sectional and longitudinal analysis of HIV RNA, proinflammatory cytokines (IL-6, IL-10, INF-γ, TNF-α, TGF-β1, and TGF-β2) and chemokines (MIP-1α, MIP-1β, and MCP-1) in plasma and cerebrospinal fluid (CSF) of HIV-infected patients with CD4 <200/μL. Results. HAND was diagnosed at baseline in 6/12 patients. Baseline CSF HIV-RNA was comparable in patients with or without HAND, whereas CSF concentration of IL-6 and MIP-1β, proinflammatory cytokines, was increased in HAND patients. CSF evaluation at 12 weeks was available in 10/12 cases. ART greatly reduced HIV-RNA in all patients. Nevertheless, IL-6 and MIP-1β remained elevated after 12 weeks of therapy in HAND patients, in whom CSF HIV RNA decay was slower than the plasmatic one as well. Conclusion. Immune activation, as indicated by inflammatory cytokines, but not higher levels of HIV-RNA is observed in advanced naïve HIV-infected patients with HAND. In HAND patients, ART introduction resulted in a less rapid clearance of CSF viremia compared to plasma and no modifications of intratechal immune activation.
format Article
id doaj-art-c1a8f8056d9c4aac8737d05aa727e121
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-c1a8f8056d9c4aac8737d05aa727e1212025-02-03T01:10:49ZengWileyClinical and Developmental Immunology1740-25221740-25302012-01-01201210.1155/2012/467154467154Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune ActivationMonica Airoldi0Alessandra Bandera1Daria Trabattoni2Benedetta Tagliabue3Beatrice Arosio4Alessandro Soria5Veronica Rainone6Giuseppe Lapadula7Giorgio Annoni8Mario Clerici9Andrea Gori10Division of Infectious Diseases, Department of Internal Medicine, “San Gerardo” Hospital, University of Milan-Bicocca, 20900 Monza, ItalyDivision of Infectious Diseases, Department of Internal Medicine, “San Gerardo” Hospital, University of Milan-Bicocca, 20900 Monza, ItalyLITA VIALBA, University of Milan, 20157 Milan, ItalyDepartment of Clinical Medicine and Prevention, University of Milan-Bicocca, SCC Geriatrics, 20900 Monza, ItalyGeriatric Unit, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, 20122 Milan, ItalyDivision of Infectious Diseases, Department of Internal Medicine, “San Gerardo” Hospital, University of Milan-Bicocca, 20900 Monza, ItalyLITA VIALBA, University of Milan, 20157 Milan, ItalyDivision of Infectious Diseases, Department of Internal Medicine, “San Gerardo” Hospital, University of Milan-Bicocca, 20900 Monza, ItalyDepartment of Clinical Medicine and Prevention, University of Milan-Bicocca, SCC Geriatrics, 20900 Monza, ItalyLITA VIALBA, University of Milan, 20157 Milan, ItalyDivision of Infectious Diseases, Department of Internal Medicine, “San Gerardo” Hospital, University of Milan-Bicocca, 20900 Monza, ItalyObjective. To investigate intrathecal immune activation parameters and HIV-RNA in HIV-associated neurocognitive disorders (HAND) of advanced naïve HIV-infected patients and to evaluate their dynamics before and after initiation of antiretroviral therapy (ART). Methods. Cross-sectional and longitudinal analysis of HIV RNA, proinflammatory cytokines (IL-6, IL-10, INF-γ, TNF-α, TGF-β1, and TGF-β2) and chemokines (MIP-1α, MIP-1β, and MCP-1) in plasma and cerebrospinal fluid (CSF) of HIV-infected patients with CD4 <200/μL. Results. HAND was diagnosed at baseline in 6/12 patients. Baseline CSF HIV-RNA was comparable in patients with or without HAND, whereas CSF concentration of IL-6 and MIP-1β, proinflammatory cytokines, was increased in HAND patients. CSF evaluation at 12 weeks was available in 10/12 cases. ART greatly reduced HIV-RNA in all patients. Nevertheless, IL-6 and MIP-1β remained elevated after 12 weeks of therapy in HAND patients, in whom CSF HIV RNA decay was slower than the plasmatic one as well. Conclusion. Immune activation, as indicated by inflammatory cytokines, but not higher levels of HIV-RNA is observed in advanced naïve HIV-infected patients with HAND. In HAND patients, ART introduction resulted in a less rapid clearance of CSF viremia compared to plasma and no modifications of intratechal immune activation.http://dx.doi.org/10.1155/2012/467154
spellingShingle Monica Airoldi
Alessandra Bandera
Daria Trabattoni
Benedetta Tagliabue
Beatrice Arosio
Alessandro Soria
Veronica Rainone
Giuseppe Lapadula
Giorgio Annoni
Mario Clerici
Andrea Gori
Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation
Clinical and Developmental Immunology
title Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation
title_full Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation
title_fullStr Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation
title_full_unstemmed Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation
title_short Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation
title_sort neurocognitive impairment in hiv infected naive patients with advanced disease the role of virus and intrathecal immune activation
url http://dx.doi.org/10.1155/2012/467154
work_keys_str_mv AT monicaairoldi neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT alessandrabandera neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT dariatrabattoni neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT benedettatagliabue neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT beatricearosio neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT alessandrosoria neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT veronicarainone neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT giuseppelapadula neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT giorgioannoni neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT marioclerici neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation
AT andreagori neurocognitiveimpairmentinhivinfectednaivepatientswithadvanceddiseasetheroleofvirusandintrathecalimmuneactivation